Robert Bitterman
Vermögen: 456 677 $ am 31.05.2026
Vermögen: 456 677 $ am 31.05.2026
Robert J.
Bitterman was the founder of Cutanea Life Sciences, Inc., founded in 2005, where the title held was Executive Chairman from 2019 to 2022.
Current jobs include Chairman, President & Chief Executive Officer at Phio Pharmaceuticals Corp.
since 2024, and Member at the Dermatology Foundation, Women's Dermatologic Society, and Business Leaders Network.
Former jobs include President & Chief Executive Officer at Fibrocell Science, Inc. from 2004 to 2005, President & Chief Executive Officer at Isolagen Technologies, Inc., President & Chief Executive Officer at Maruho Co., Ltd., and President & General Manager at Dermik Laboratories, Inc. from 1994 to 2004.
Education history includes undergraduate studies at College of the Holy Cross (Massachusetts), an MBA from Boston University, and a doctorate from New York College of Podiatric Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.02.2026 | 411 421 ( 3,54 % ) | 456 677 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PHIO PHARMACEUTICALS CORP. | Vorstandsvorsitzender | - |
Women's Dermatologic Society | Corporate Officer/Principal | - |
Dermatology Foundation | Corporate Officer/Principal | - |
Business Leaders Network | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
Cutanea Life Sciences, Inc.
Cutanea Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercialises innovative dermatology related products | Vorstandsvorsitzender | 01.03.2019 |
| FIBROCELL SCIENCE, INC. | Vorstandsvorsitzender | 25.04.2005 |
Dermik Laboratories, Inc.
Dermik Laboratories, Inc. Household/Personal CareConsumer Non-Durables Manufactures health and skin care products | Präsident | 01.01.2004 |
Isolagen Technologies, Inc.
Isolagen Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops cellular technology | Vorstandsvorsitzender | - |
Maruho Co., Ltd.
Maruho Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacture, and marketing of pharmaceutical products | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
Fibrocell Science, Inc.
Fibrocell Science, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an autologous cell and gene therapy company focused on development of personalized biologics to treat rare skin and connective tissue diseases | Commercial Services |
Cutanea Life Sciences, Inc.
Cutanea Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercialises innovative dermatology related products | Health Technology |
College of the Holy Cross (Massachusetts)
College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Isolagen Technologies, Inc.
Isolagen Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops cellular technology | Commercial Services |
Dermik Laboratories, Inc.
Dermik Laboratories, Inc. Household/Personal CareConsumer Non-Durables Manufactures health and skin care products | Consumer Non-Durables |
Dermatology Foundation | |
Maruho Co., Ltd.
Maruho Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacture, and marketing of pharmaceutical products | Health Technology |
Women's Dermatologic Society | |
New York College of Podiatric Medicine
New York College of Podiatric Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. BiotechnologyHealth Technology Develops RNAi-based medical technologies and therapies | Health Technology |
Business Leaders Network | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen